Fundz

G1 Therapeutics, Inc. reported raising $47 Million in an initial SEC Form D filing, from an offering of $50 Million

PRIVATEMay 11, 2016$47M of $50M raised

Amount Raised

$47 Million

$47 Million sold, per SEC Form D (first sale May 11, 2016)

Round Type

Venture

Research Triangle ParkBiotechnologyHealth CareTherapeutics

Quick answer

G1 Therapeutics, Inc. raised $47 Million in a funding round, dated May 11, 2016. G1 Therapeutics, Inc. is based in Research Triangle Park, North Carolina, United States.

How much did G1 Therapeutics, Inc. raise?
G1 Therapeutics, Inc. raised $47 Million in a funding round on May 11, 2016.
What does G1 Therapeutics, Inc. do?
G1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company whose mission is to develop and deliver next-generation therapies that improve the lives of those affected by cancer, including the..
Where is G1 Therapeutics, Inc. based and how big is it?
G1 Therapeutics, Inc. is based in Research Triangle Park, North Carolina, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as G1 Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

Who to call at G1 Therapeutics, Inc., and when

A new round usually means G1 Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day G1 Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at G1 Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at G1 Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

G1 Therapeutics, Inc.

Location

79 T.W. ALEXANDER DRIVE

Research Triangle Park, North Carolina, United States

About

G1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company whose mission is to develop and deliver next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). The Company is also evaluating therapies in combination with cytotoxic therapies and/or immunotherapy in areas of high unmet need including triple-negative breast cancer and extensive stage small cell lung cancer. G1’s goal is to provide innovative therapeutic advances for people living with cancer. G1 is based in Research Triangle Park, N.C. For additional information, please visit http://www.g1therapeutics.com and follow us on X (formerly known as Twitter) @G1Therapeutics and LinkedIn. G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment G1 Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for G1 Therapeutics, Inc.'s next move

See what Strategic adds

G1 Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.